Real-world economic impact of onabotulinumtoxina in patients with chronic migraine

被引：0
|
作者：
Rothrock, J. F. [1 ]
Bloudek, L. M. [2 ]
Houle, T. T. [3 ]
Andress-Rothrock, D. [4 ]
Hanlon, C. [1 ]
Varon, S. F. [2 ]
机构：
[1] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[2] Allergan Pharmaceut Inc, Irvine, CA 92715 USA
[3] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[4] Univ Alabama Birmingham, Headache Treatment & Res Program, Birmingham, AL USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2013年 / 14卷
关键词：
Migraine; Chronic Migraine; Episodic Migraine; onabotulinumtoxinA; Urgent Care Center;
D O I：
10.1186/1129-2377-14-S1-P216
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-world economic impact of onabotulinumtoxina in patients with chronic migraine
    JF Rothrock
    LM Bloudek
    TT Houle
    D Andress-Rothrock
    C Hanlon
    SF Varon
    The Journal of Headache and Pain, 2013, 14
  • [2] Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine
    Rothrock, John F.
    Bloudek, Lisa M.
    Houle, Timothy T.
    Andress-Rothrock, Diane
    Varon, Sepideh F.
    HEADACHE, 2014, 54 (10): : 1565 - 1573
  • [3] Real-World Economic Impact of OnabotulinumtoxinA in Patients with Chronic Migraine
    Rothrock, John
    Bloudek, Lisa
    Houle, Timothy
    Andress-Rothrock, Diane
    Hanlon, Christopher
    Varon, Sepideh
    NEUROLOGY, 2012, 78
  • [4] Clinical treatment of chronic and episodic migraine with onabotulinumtoxinA in a real-world setting
    Velasco-Juanes F.
    Gómez-Esteban J.C.
    Fernández-Valle T.
    Matute-Nieves A.
    Almeida-Velasco J.
    Lloret-Villas M.I.
    Ugarriza-Serrano I.
    Drugs & Therapy Perspectives, 2018, 34 (7) : 335 - 343
  • [5] Real-world evidence for chronic migraine control in patients receiving treatment with CGRP mAbs and onabotulinumtoxinA
    Blumenfeld, A.
    Frishberg, B.
    Schim, J.
    Hughes, O.
    Sommer, K.
    Adams, A. Manack
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 152 - 153
  • [6] Real-World Retrospective Safety Analysis of OnabotulinumtoxinA for the Treatment of Patients with Concurrent Cervical Dystonia and Chronic Migraine
    Rhyne, C.
    Martinez, K.
    Stoilova, J.
    Patel, A.
    Ifantides, K. Becker
    Singh, R.
    Yushmanova, I.
    Sadeghi, M.
    Battucci, S.
    Forde, G.
    MOVEMENT DISORDERS, 2023, 38 : S350 - S351
  • [7] Real-world Retrospective Safety Analysis of OnabotulinumtoxinA for the Treatment of Patients With Concurrent Cervical Dystonia and Chronic Migraine
    Rhyne, Christopher
    Martinez, Kenneth
    Stoilova, Juliana
    Patel, Atul
    Ifantides, Kim Becker
    Singh, Ritu
    Yushmanova, Irina
    Sadeghi, Marjan
    Battucci, Simona
    Grace, Forde
    TOXICON, 2024, 237 : 73 - 74
  • [8] OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients
    Wong, Ho-Tin
    Khalil, Modar
    Ahmed, Fayyaz
    JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
  • [9] OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients
    Ho-Tin Wong
    Modar Khalil
    Fayyaz Ahmed
    The Journal of Headache and Pain, 2020, 21
  • [10] Real-world experience of OnabotulinumtoxinA treatment in female patients with chronic migraine: a qualitative study using in-depth interviews
    Palacios-Cena, Domingo
    Ordas-Bandera, Carlos
    Casas-Limon, Javier
    Perez-Corrales, Jorge
    Gueita-Rodriguez, Javier
    Arias-Navalon, Jose A.
    Cuadrado, Maria-Luz
    ANNALS OF MEDICINE, 2023, 55 (02)
12345